Scientists Say New Prognostic Score Can Predict Mesothelioma Surgical Outcomes, According to Surviving Mesothelioma

Share Article

Canadian researchers have developed a new scoring system they say can help determine which mesothelioma patients are the best candidates for radical surgery.

Predicting Surgery Outcomes

Prognostic Score for Mesothelioma Surgery

...PLR is simple and useful for predicting the prognosis of patients with malignant pleural mesothelioma undergoing EPP.

Doctors say a test designed to measure the ratio of platelets to lymphocytes in the blood is a good predictor of mesothelioma survival after surgery. Their new report is the subject of a new article on the Surviving Mesothelioma website. Click here to read it now.

Researchers at the University of Toronto and Kyushu University in Japan analyzed the platelet-to-lymphocyte ratio (PLR) in 65 Canadian mesothelioma patients and 32 Japanese patients who underwent extrapleural pneumonectomy (EPP) surgery for pleural mesothelioma.

According to the article in the Journal of Thoracic Disease, mesothelioma patients with the highest PLR scores had the shortest post-surgical survival.

“The new prognostic score using PLR is simple and useful for predicting the prognosis of patients with malignant pleural mesothelioma undergoing EPP,” writes lead investigator Tetsuzo Tagawa of Kyushu University in Fukuoka, Japan.

“Radical pleural mesothelioma surgery remains controversial. The hope is that this new scoring system may help make the decision-making process a little easier for both mesothelioma patients and clinicians,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.

Read more about the relationship between PLR score and mesothelioma surgery outcomes in Blood Test Predicts Mesothelioma Surgery Outcomes, now available on the Surviving Mesothelioma website.

Tagawa, T, et al, “Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy”, November 2015, pp. 1898-1906,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website